76,90 €
A modern and practical dosing pen designed for precise and convenient administration of research compounds. Its elegant design, compact construction, and user-friendly operation allow efficient handling in laboratory environments. CJC-1295 + Ipamorelin is a highly regarded research combination of two peptides in an optimal 1:1 ratio (5 mg + 5 mg). The combination of a GHRH analog and a selective GHRP secretagogue creates a powerful synergistic effect that is the subject of intensive scientific research in the fields of pulsatile growth hormone stimulation, tissue regeneration, and cellular rejuvenation. Needles are not included in the package and are not available in our product range. The product is intended exclusively for scientific and research purposes.
0 in stock
The combination of CJC-1295 and Ipamorelin represents one of the most effective and widely studied protocols in modern endocrinology and cellular biology. This product combines two different types of secretagogues in a precise ratio of 5 mg CJC-1295 (without DAC / Mod GRF 1-29) and 5 mg Ipamorelin in 2 ml of solution. In scientific research, this combination is utilized because of its ability to act simultaneously on two distinct pathways within the pituitary gland, resulting in amplification of the body’s natural growth hormone (GH) secretory pulse without the risk of undesirable increases in cortisol or prolactin.
The dosing pen contains a total of 10 mg of highly purified compounds in 2 ml of solution, providing a total concentration of 5 mg/ml (2.5 mg/ml CJC-1295 + 2.5 mg/ml Ipamorelin). Calculated for precise dosing within research protocols:
1 ml = 100 units (IU) = 100 clicks
0.5 ml (one full rotation of the mechanism) = 50 clicks
Examples of mixture dosing (CJC-1295 + Ipamorelin) for research purposes:
1 click = 0.05 mg (50 mcg mixture = 25 mcg of each peptide)
2 clicks = 0.10 mg (100 mcg mixture = 50 mcg of each peptide)
4 clicks = 0.20 mg (200 mcg mixture = 100 mcg of each peptide)
10 clicks (0.1 ml) = 0.50 mg (500 mcg mixture = 250 mcg of each peptide)
20 clicks (0.2 ml) = 1.00 mg (1000 mcg mixture = 500 mcg of each peptide)
This mechanical system guarantees absolute precision, repeatability, and flexibility when adjusting microdoses according to the requirements of a specific laboratory protocol without the need for manual mixing of two separate vials.
Research-Studied Effects
The primary focus of research on this combination is the so-called dual signaling mechanism. CJC-1295 acts as a GHRH analog and stimulates growth hormone production, while Ipamorelin (acting as a ghrelin mimetic / GHRP) binds to ghrelin receptors, thereby suppressing somatostatin—the hormone responsible for inhibiting growth hormone release. The result of this synergy is a powerful pituitary response that is significantly stronger than when either compound is administered independently.
In in vivo models, researchers evaluate the influence of this cascade on the subsequent release of IGF-1 (Insulin-like Growth Factor-1) in the liver. Research data suggest that this combination significantly accelerates protein synthesis, stimulates both hypertrophy and hyperplasia of muscle cells, supports bone density, and dramatically shortens the time required for the repair of damaged tendons, ligaments, and joint structures. Furthermore, Ipamorelin is highly valued in scientific studies for its selectivity because, unlike older peptides (GHRP-2, GHRP-6), it does not stimulate hunger receptors and does not affect stress hormone levels.
Scientific Context and References
The synergistic effect of combining GHRH and GHRP has been thoroughly documented in dozens of clinical and preclinical studies available in the international medical database PubMed. Research focuses on maintaining a youthful cellular profile, protecting tissues from catabolism, and influencing lipid metabolism (promoting lipolysis and reducing visceral fat).
Long-term safety monitoring and evaluation of glucose tolerance in research subjects are the focus of ongoing clinical studies listed on ClinicalTrials.gov, where this fixed combination represents one of the most promising models for therapeutic management associated with the manifestations of biological aging.
The Royal Peptides dosing pen provides a modern, safe, and highly sterile solution for handling this advanced molecular blend under controlled laboratory conditions.
The product is intended exclusively for scientific and research purposes. Not for direct human consumption.
